Go to All Subject -

Pharmacology

Online Study Material, Lecturing Notes, Assignment, Reference, Wiki and important questions and answers

Pharmacology


-:- Introduction - Basic & Clinical Pharmacology
-:- The History of Pharmacologyogy
-:- Pharmacology & Genetics
-:- Pharmacology and the Pharmaceutical Industry
-:- The Nature of Drugs
-:- Drug-Body Interactions
-:- Pharmacodynamic Principles
-:- Pharmacokinetic Principles
-:- Drug Groups
-:- Drug Receptors & Pharmacodynamics
-:- Macromolecular Nature of Drug Receptors
-:- Relation Between Drug Concentration & Response
-:- Signaling Mechanisms & Drug Action
-:- Intracellular Receptors for Lipid-Soluble Agents
-:- Ligand-Regulated Transmembrane Enzymes Including Receptor Tyrosine Kinases
-:- Cytokine Receptors
-:- Ligand- and Voltage-Gated Channels
-:- G Proteins & Second Messengers
-:- Receptor Regulation
-:- Well-Established Second Messengers
-:- Interplay among Signaling Mechanisms
-:- Phosphorylation: A Common Theme
-:- Receptor Classes & Drug Development
-:- Relation Between Drug Dose & Clinical Response
-:- Dose & Response in Patients
-:- Variation in Drug Responsiveness
-:- Clinical Selectivity: Beneficial versus Toxic Effects of Drugs
-:- Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action
-:- Pharmacokinetics
-:- Volume of Distribution - Pharmacokinetics
-:- Clearance - Pharmacokinetics
-:- Half-Life - Pharmacokinetics
-:- Drug Accumulation - Pharmacokinetics
-:- Bioavailability - Pharmacokinetics
-:- The Time Course of Drug Effect
-:- The Target Concentration Approach to Designing a Rational Dosage Regimen
-:- Target Concentration Intervention: Application of Pharmacokinetics & Pharmacodynamics to Dose Individualization
-:- Interpretation of Drug Concentration Measurements
-:- Drug Biotransformation
-:- Why is Drug Biotransformation Necessary?
-:- The Role of Biotransformation In Drug Disposition
-:- Where Do Drug Biotransformations Occur?
-:- Microsomal Mixed Function Oxidase System & Phase I Reactions
-:- Human Liver P450 Enzymes
-:- Phase II Reactions
-:- Metabolism of Drugs to Toxic Products
-:- Clinical Relevance of Drug Metabolism
-:- Development & Regulation of Drugs
-:- The Pharmaceutical Industry
-:- Drug Discovery
-:- Preclinical Safety & Toxicity Testing
-:- Evaluation in Humans
-:- Confounding Factors in Clinical Trials
-:- The Food & Drug Administration - Evaluation in Humans
-:- Clinical Trials: The IND & NDA - Evaluation in Humans
-:- Conflicts of Interest, Adverse Drug Reactions - Evaluation in Humans
-:- Orphan Drugs & Treatment of Rare Diseases - Evaluation in Humans
-:- Introduction to Autonomic Pharmacology
-:- Anatomy of the Autonomic Nervous System
-:- Neurotransmitter Chemistry of the Autonomic Nervous System
-:- Autonomic Receptors
-:- Nonadrenergic, Noncholinergic (NANC) Neurons
-:- Functional Organization of Autonomic Activity
-:- Pharmacologic Modification of Autonomic Function
-:- Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs
-:- Spectrum of Action of Cholinomimetic Drugs
-:- Mode of Action of Cholinomimetic Drugs
-:- Basic Pharmacology of the Direct Acting Cholinoceptor Stimulants
-:- Basic Pharmacology of the Indirect Acting Cholinomimetics
-:- Clinical Pharmacology of the Cholinomimetics
-:- Cholinoceptor Blocking Drugs
-:- Basic Pharmacology of the Muscarinic Receptor Blocking Drugs
-:- Clinical Pharmacology of the Muscarinic Receptor Blocking Drugs
-:- Basic & Clinical Pharmacology of the Ganglion Blocking Drugs
-:- Adrenoceptor Agonists & Sympathomimetic Drugs
-:- Molecular Pharmacology Underlying the Actions of Sympathomimetic Drugs
-:- Medicinal Chemistry of Sympathomimetic Drugs
-:- Cardiovascular System - Organ System Effects of Sympathomimetic Drugs
-:- Noncardiac Effects of Sympathomimetics - Organ System Effects of Sympathomimetic Drugs
-:- Endogenous Catecholamines
-:- Direct-Acting Sympathomimetics
-:- Mixed-Acting Sympathomimetics
-:- Indirect-Acting Sympathomimetics
-:- Therapeutic Uses of Sympathomimetic Drugs
-:- Adrenoceptor Antagonist Drugs
-:- Basic Pharmacology of the Alpha Receptor Antagonist Drugs
-:- Specific Agents
-:- Other Alpha-Adrenoceptor Antagonists
-:- Clinical Pharmacology of the Alpha Receptor Blocking Drugs
-:- Basic Pharmacology of the Beta Receptor Antagonist Drugs
-:- Pharmacokinetic Properties of the Beta-Receptor Antagonists
-:- Pharmacodynamics of the Beta-Receptor Antagonist Drugs
-:- Specific Agents
-:- Clinical Pharmacology of the Beta Receptor Blocking Drugs
-:- Choice of a Beta-Adrenoceptor Antagonist Drug
-:- Clinical Toxicity Of The Beta-Receptor Antagonist Drugs
-:- Antihypertensive Agents
-:- Hypertension & Regulation of Blood Pressure
-:- Basic Pharmacology of Antihypertensive Agents
-:- Drugs that Alter Sodium & Water Balance
-:- Drugs That Alter Sympathetic Nervous System Function
-:- Centrally Acting Sympathoplegic Drugs
-:- Methyldopa
-:- Clonidine
-:- Ganglion-Blocking Agents
-:- Adrenergic Neuron-Blocking Agents
-:- Beta-Adrenoceptor-Blocking Agents
-:- Prazosin & Other Alpha1 Blockers
-:- Vasodilators
-:- Hydralazine
-:- Minoxidil
-:- Sodium Nitroprusside
-:- Diazoxide
-:- Fenoldopam
-:- Calcium Channel Blockers
-:- Inhibitors of Angiotensin
-:- Angiotensin-Converting Enzyme (ACE) Inhibitors
-:- Angiotensin Receptor-Blocking Agents
-:- Clinical Pharmacology of Antihypertensive Agents
-:- Outpatient Therapy of Hypertension
-:- Management of Hypertensive Emergencies
-:- Vasodilators & the Treatment of Angina Pectoris
-:- Pathophysiology of Angina
-:- Basic Pharmacology of Drugs Used to Treat Angina
-:- Nitrates & Nitrites
-:- Drugs Used in the Treatment of Erectile Dysfunction
-:- Calcium Channel-Blocking Drugs
-:- Beta-Blocking Drugs
-:- Newer Antianginal Drugs
-:- Clinical Pharmacology of Drugs Used to Treat Angina
-:- Treatment of Peripheral Artery Disease (PAD) & Intermittent Claudication
-:- Drugs Used in Heart Failure
-:- Control of Normal Cardiac Contractility
-:- Pathophysiology of Heart Failure
-:- Pathophysiology of Cardiac Performance
-:- Other Positive Inotropic Drugs Used in Heart Failure
-:- Bipyridines
-:- Beta-Adrenoceptor Agonists
-:- Basic Pharmacology of Drugs Used in Heart Failure
-:- Drugs Without Positive Inotropic Effects Used in Heart Failure
-:- Clinical Pharmacology of Drugs Used in Heart Failure
-:- Management of Chronic Heart Failure
-:- Management of Diastolic Heart Failure
-:- Management of Acute Heart Failure
-:- Agents Used in Cardiac Arrhythmias
-:- Electrophysiology of Normal Cardiac Rhythm
-:- Mechanisms of Arrhythmias
-:- Basic Pharmacology of the Antiarrhythmic Agents
-:- Specific Antiarrhythmic Agents
-:- Procainamide (Subgroup 1A)
-:- Quinidine (SubGroup 1A)
-:- Disopyramide (SubGroup 1A)
-:- Lidocaine (SubGroup 1B)
-:- Mexiletine (SubGroup 1B)
-:- Flecainide (Subgroup 1C)
-:- Propafenone (Subgroup 1C)
-:- Moricizine (Subgroup 1C)
-:- Beta-Adrenoceptor–Blocking Drugs (Class 2)
-:- Drugs That Prolong Effective Refractory Period by Prolonging the Action Potential (Class 3)
-:- Amiodarone
-:- Dronedarone
-:- Vernakalant
-:- Sotalol
-:- Dofetilide
-:- Ibutilide
-:- Calcium Channel-Blocking Drugs (Class 4)
-:- Verapamil
-:- Adenosine - Antiarrhythmic Agents
-:- Magnesium - Antiarrhythmic Agents
-:- Potassium - Antiarrhythmic Agents
-:- Principles in the Clinical Use of Antiarrhythmic Agents
-:- Diuretic Agents
-:- Proximal Tubule - Renal Tubule Transport Mechanisms
-:- Loop of Henle - Renal Tubule Transport Mechanisms
-:- Distal Convoluted Tubule - Renal Tubule Transport Mechanisms
-:- Collecting Tubule System - Renal Tubule Transport Mechanisms
-:- Renal Autacoids - Renal Tubule Transport Mechanisms
-:- Adenosine
-:- Prostaglandins
-:- Peptides
-:- Carbonic Anhydrase Inhibitors
-:- Adenosine A1-Receptor Antagonists
-:- Loop Diuretics
-:- Thiazides
-:- Potassium-Sparing Diuretics
-:- Agents That Alter Water Excretion (Aquaretics)
-:- Diuretic Combinations
-:- Edematous States
-:- Nonedematous States
-:- Histamine
-:- Basic Pharmacology of Histamine
-:- Clinical Pharmacology of Histamine
-:- Histamine Antagonists
-:- Histamine Receptor Antagonists
-:- Basic Pharmacology of H1-Receptor Antagonists
-:- Clinical Pharmacology of H1-Receptor Antagonists
-:- H2-Receptor Antagonists
-:- H3- & H4-Receptor Antagonists
-:- Serotonin 5 Hydroxytryptamine
-:- Basic Pharmacology of Serotonin
-:- Melatonin Pharmacology
-:- Serotonin Syndrome and Similar Syndromes
-:- Clinical Pharmacology of Serotonin
-:- Serotonin Antagonists
-:- Serotonin-Receptor Antagonists
-:- The Ergot Alkaloids
-:- Basic Pharmacology of Ergot Alkaloids
-:- Clinical Pharmacology of Ergot Alkaloids
-:- Vasoactive Peptides
-:- Biosynthesis of Angiotensin
-:- Actions of Angiotensin II
-:- Angiotensin Receptors & Mechanism of Action
-:- Biosynthesis of Kinins
-:- Inhibition of the Renin-Angiotensin System
-:- Formation of Kinins in Plasma & Tissues
-:- Physiologic & Pathologic Effects of Kinins
-:- Kinin Receptors & Mechanisms of Action
-:- Metabolism of Kinins
-:- Drugs Affecting the Kallikrein-Kinin System
-:- Vasopressin
-:- Vasopressin Receptors & Antagonists
-:- Natriuretic Peptides
-:- Vasopeptidase Inhibitors
-:- Endothelins
-:- Inhibitors of Endothelin Synthesis & Action
-:- Vasoactive Intestinal Peptide
-:- Substance P
-:- Neurotensin
-:- Calcitonin Gene Related Peptide
-:- Adrenomedullin
-:- Neuropeptide Y
-:- Urotensin
-:- Arachidonic Acid & Other Polyunsaturated Precursors
-:- Synthesis of Eicosanoids
-:- Receptor Mechanisms - Mechanisms & Effects of Eicosanoids
-:- Effects of Prostaglandins & Thromboxanes
-:- Effects of Lipoxygenase & Cytochrome P450-Derived Metabolites
-:- Inhibition of Eicosanoid Synthesis
-:- Clinical Pharmacology of Eicosanoids
-:- Dietary Manipulation of Arachidonic Acid Metabolism
-:- Discovery of Endogenously Generated Nitric Oxide
-:- Nitric Oxide Synthesis, Signaling Mechanisms, & Inactivation
-:- Pharmacologic Manipulation of Nitric Oxide
-:- Vascular Effects - Nitric Oxide in Disease
-:- Septic Shock - Nitric Oxide in Disease
-:- Infection & Inflammation - Nitric Oxide in Disease
-:- The Central Nervous System - Nitric Oxide in Disease
-:- The Peripheral Nervous System - Nitric Oxide in Disease
-:- Respiratory Disorders - Nitric Oxide in Disease
-:- Drugs Used in Asthma
-:- Pathogenesis of Asthma
-:- Sympathomimetic Agents - Basic Pharmacology of Agents Used in the Treatment of Asthma
-:- Methylxanthine Drugs - Basic Pharmacology of Agents Used in the Treatment of Asthma
-:- Antimuscarinic Agents - Basic Pharmacology of Agents Used in the Treatment of Asthma
-:- Corticosteroids - Basic Pharmacology of Agents Used in the Treatment of Asthma
-:- Leukotriene Pathway Inhibitors - Basic Pharmacology of Agents Used in the Treatment of Asthma
-:- Anti-IgE Monoclonal Antibodies - Drugs in the Treatment of Asthma
-:- Cromolyn & Nedocromil
-:- Clinical Pharmacology of Drugs Used In the Treatment of Asthma
-:- Bronchodilators
-:- Muscarinic Antagonists
-:- Corticosteroids
-:- Leukotriene Antagonists; Cromolyn & Nedocromil
-:- Anti-Ige Monoclonal Antibody
-:- Management of Acute Asthma
-:- Prospects for Prevention of Asthma
-:- Treatment Of Chronic Obstructive Pulmonary Disease (COPD)
-:- Introduction to the Pharmacology of Central Nervous System (CNS) Drugs
-:- Methods for the Study of Central Nervous System (CNS) Pharmacology
-:- Ion Channels & Neurotransmitter Receptors
-:- The Synapse & Synaptic Potentials
-:- Sites of Drug Action
-:- Identification of Central Neurotransmitters
-:- Cellular Organization of the Brain
-:- Central Neurotransmitters
-:- Basic Pharmacology of Sedative Hypnotics
-:- Chemical Classification - Basic Pharmacology of Sedative Hypnotics
-:- Pharmacokinetics - Basic Pharmacology of Sedative Hypnotics
-:- Pharmacodynamics of Benzodiazepines, Barbiturates, & Newer Hypnotics
-:- Tolerance & Dependence - Basic Pharmacology of Sedative Hypnotics
-:- Benzodiazepine Antagonists: Flumazenil
-:- Treatment of Anxiety States
-:- Treatment of Sleep Problems
-:- Other Therapeutic Uses
-:- Clinical Toxicology of Sedative-Hypnotics
-:- The Alcohols
-:- Basic Pharmacology of Ethanol: Pharmacokinetics
-:- Pharmacodynamics of Acute Ethanol Consumption
-:- Consequences of Chronic Alcohol Consumption
-:- What Can Drunken Worms, Flies, and Mice Tell Us about Alcohol?
-:- Alcohol-Drug Interactions
-:- Clinical Pharmacology of Ethanol
-:- Management of Acute Alcohol Intoxication
-:- Management of Alcohol Withdrawal Syndrome
-:- Treatment of Alcoholism
-:- Pharmacology of Methanol
-:- Pharmacology of Ethylene Glycol
-:- Antiseizure Drugs
-:- Drug Development for Epilepsy - Antiseizure Drugs
-:- Basic Pharmacology of Antiseizure Drugs
-:- Drugs Used in Partial Seizures Generalized Tonic-Clonic Seizures
-:- Phenytoin
-:- Mephenytoin, Ethotoin, & Phenacemide
-:- Carbamazepine
-:- Oxcarbazepine
-:- Eslicarbazine
-:- Phenobarbital
-:- Primidone
-:- Felbamate
-:- Gabapentin & Pregabalin
-:- Lacosamide
-:- Lamotrigine
-:- Levetiracetam
-:- Retigabine (Ezogabine)
-:- Rufinamide
-:- Stiripentol
-:- Tiagabine
-:- Topiramate
-:- Vigabatrin
-:- Zonisamide
-:- Ethosuximide
-:- Phensuximide & Methsuximide
-:- Valproic Acid & Sodium Valproate
-:- Oxazolidinediones
-:- Benzodiazepines
-:- Acetazolamide
-:- Seizure Classification - Clinical Pharmacology of Antiseizure Drugs
-:- Therapeutic Strategy - Clinical Pharmacology of Antiseizure Drugs
-:- Management of Epilepsy
-:- Special Aspects of the Toxicology of Antiseizure Drugs
-:- General Anesthetics
-:- Mechanism of General Anesthetic Action
-:- Inhaled Anesthetics
-:- Pharmacokinetics - Inhaled Anesthetics
-:- Pharmacodynamics - Inhaled Anesthetics
-:- What Does Anesthesia Represent & Where Does It Work?
-:- Intravenous Anesthetics
-:- Propofol - Intravenous Anesthetics
-:- Fospropofol - Intravenous Anesthetics
-:- Barbiturates - Intravenous Anesthetics
-:- Benzodiazepines - Intravenous Anesthetics
-:- Etomidate - Intravenous Anesthetics
-:- Ketamine - Intravenous Anesthetics
-:- Dexmedetomidine - Intravenous Anesthetics
-:- Opioid Analgesics - Intravenous Anesthetics
-:- Current Clinical Practice - Intravenous Anesthetics
-:- Local Anesthetics
-:- Basic Pharmacology of Local Anesthetics
-:- Historical Development of Local Anesthesia
-:- Clinical Pharmacology of Local Anesthetics
-:- Lipid Resuscitation
-:- Commonly Used Local Anesthetics & Their Applications
-:- Skeletal Muscle Relaxants
-:- Neuromuscular Blocking Drugs
-:- Basic Pharmacology of Neuromuscular Blocking Drugs
-:- Clinical Pharmacology of Neuromuscular Blocking Drugs
-:- Spasmolytic Drugs
-:- Diazepam - Spasmolytic Drugs
-:- Baclofen
-:- Tizanidine - Spasmolytic Drugs
-:- Dantrolene - Spasmolytic Drugs
-:- Botulinum Toxin - Spasmolytic Drugs
-:- Drugs Used to Treat Acute Local Muscle Spasm
-:- Pharmacologic Management of Parkinsonism & Other Movement Disorders
-:- Parkinsonism
-:- Levodopa
-:- Dopamine Receptor Agonists
-:- Monoamine Oxidase Inhibitors
-:- Catechol-O-Methyltransferase Inhibitors
-:- Apomorphine
-:- Amantadine
-:- Acetylcholine-Blocking Drugs
-:- Surgical Procedures - Parkinsonism
-:- Neuroprotective Therapy - Parkinsonism
-:- Gene Therapy - Parkinsonism
-:- General Comments On Drug Management of Patients With Parkinsonism
-:- Drug-Induced Parkinsonism
-:- MPTP & Parkinsonism
-:- Other Movement Disorders
-:- Antipsychotic Agents
-:- The Serotonin Hypothesis of Schizophrenia
-:- The Dopamine Hypothesis of Schizophrenia
-:- The Glutamate Hypothesis of Schizophrenia
-:- Basic Pharmacology of Antipsychotic Agents
-:- Clinical Pharmacology of Antipsychotic Agents
-:- Lithium, Mood Stabilizing Drugs, & Other Treatment For Bipolar Disorder
-:- Basic Pharmacology of Lithium
-:- Clinical Pharmacology of Lithium
-:- Antidepressant Agents
-:- Pathophysiology of Major Depression
-:- Neurotrophic Hypothesis
-:- Monoamines and Other Neurotransmitters
-:- Neuroendocrine Factors in the Pathophysiology of Depression
-:- Integration of Hypotheses Regarding the Pathophysiology of Depression
-:- Basic Pharmacology of Antidepressants
-:- Clinical Indications - Clinical Pharmacology of Antidepressants
-:- Choosing an Antidepressant - Clinical Pharmacology of Antidepressants
-:- Dosing - Clinical Pharmacology of Antidepressants
-:- Adverse Effects - Clinical Pharmacology of Antidepressants
-:- Overdose - Clinical Pharmacology of Antidepressants
-:- Drug Interactions - Clinical Pharmacology of Antidepressants
-:- Basic Pharmacology of the Opioid Analgesics
-:- Pharmacokinetics - Basic Pharmacology of the Opioid Analgesics
-:- Pharmacodynamics - Basic Pharmacology of the Opioid Analgesics
-:- Clinical Pharmacology of the Opioid Analgesics
-:- Ion Channels & Novel Analgesic Targets
-:- Clinical Use of Opioid Analgesics
-:- Toxicity & Undesired Effects - Clinical Pharmacology of the Opioid Analgesics
-:- Strong Agonists
-:- MILD to Moderate Agonists
-:- Opioids With Mixed Receptor Actions
-:- Antitussives
-:- The Opioid Antagonists
-:- Drugs of Abuse
-:- Dependence Versus Addiction
-:- Addictive Drugs Increase the Level of Dopamine: Reinforcement
-:- Animal Models in Addiction Research
-:- The Dopamine Hypothesis of Addiction
-:- Dependence: Tolerance & Withdrawal - Drugs of Abuse
-:- Addiction: A Disease of Maladaptive Learning
-:- Nonaddictive Drugs of Abuse
-:- Basic Pharmacology of Drugs of Abuse
-:- Opioids - Drugs That Activate Gio-Coupled Receptors
-:- Cannabinoids - Drugs That Activate Gio-Coupled Receptors
-:- Gamma-Hydroxybutyric Acid - Drugs That Activate Gio-Coupled Receptors
-:- LSD, Mescaline, & Psilocybin
-:- Drugs that Mediate their Effects via Ionotropic Receptors
-:- Drugs that Bind to Transporters of Biogenic Amines
-:- Clinical Pharmacology of Dependence & Addiction
-:- Agents Used in Anemias; Hematopoietic Growth Factors
-:- Sickle Cell Disease and Hydroxyurea
-:- Iron - Agents Used In Anemias
-:- VITAMIN B12 - Agents Used In Anemias
-:- Folic Acid - Agents Used In Anemias
-:- Folic Acid Supplementation: A Public Health Dilemma
-:- Hematopoietic Growth Factors
-:- Erythropoietin - Hematopoietic Growth Factors
-:- Myeloid Growth Factors
-:- Megakaryocyte Growth Factors
-:- Drugs Used in Disorders of Coagulation
-:- Mechanisms of Blood Coagulation
-:- Blood Coagulation Cascade
-:- Basic Pharmacology of the Anticoagulant Drugs
-:- Indirect Thrombin Inhibitors
-:- Oral Direct Factor XA Inhibitors
-:- Direct Thrombin Inhibitors
-:- Warfarin & Other Coumarin Anticoagulants
-:- Basic Pharmacology of the Fibrinolytic Drugs
-:- Basic Pharmacology of Antiplatelet Agents
-:- Clinical Pharmacology of Drugs Used to Prevent Clotting
-:- Drugs Used in Bleeding Disorders
-:- Agents Used in Dyslipidemia
-:- Normal Lipoprotein Metabolism
-:- Lipoprotein Disorders
-:- The Primary Hypertriglyceridemias
-:- The Primary Hypercholesterolemias
-:- Secondary Hyperlipoproteinemia
-:- Competitive Inhibitors of HMG-COA Reductase (Reductase Inhibitors; 'Statins')
-:- NIACIN (Nicotinic Acid)
-:- Fibric Acid Derivatives (FIBRATES)
-:- Bile Acid-Binding Resins
-:- Inhibitors of Intestinal Sterol Absorption
-:- CETP Inhibitors and Treatment With Drug Combinations
-:- The Immune Response
-:- Therapeutic Strategies
-:- Nonsteroidalanti Inflammatory Drugs
-:- Aspirin
-:- Nonacetylated Salicylates
-:- Cox-2 Selective Inhibitors
-:- Nonselective Cox Inhibitors
-:- Choice of NSAID
-:- Disease Modifying Antirheumatic Drugs
-:- Abatacept
-:- Azathioprine
-:- Chloroquine & Hydroxychloroquine
-:- Cyclophosphamide
-:- Cyclosporine
-:- Leflunomide
-:- Methotrexate
-:- Mycophenolate Mofetil
-:- Rituximab
-:- Sulfasalazine
-:- Tocilizumab
-:- TNF-α-Blocking Agents
-:- Combination Therapy With Dmards
-:- Acetaminophen
-:- Drugs Used In Gout
-:- Colchicine
-:- Nsaids In Gout
-:- Uricosuric Agents
-:- Allopurinol
-:- Febuxostat
-:- Pegloticase
-:- Glucocorticoids
-:- Interleukin-1 Inhibitors
-:- Hypothalamic & Pituitary Hormones
-:- Anterior Pituitary & Hypothalamic Hormone Receptors
-:- Growth Hormone (Somatotropin)
-:- Treatment of Obesity
-:- Mecasermin
-:- Growth Hormone Antagonists
-:- Gonadotropins & Human Chorionic Gonadotropin
-:- Gonadotropin-Releasing Hormone & Its Analogs
-:- GNRH Receptor Antagonists
-:- Prolactin
-:- Dopamine Agonists
-:- Oxytocin
-:- Oxytocin Antagonist
-:- Vasopressin (Antidiuretic Hormone, ADH)
-:- Vasopressin Antagonists
-:- Thyroid Physiology
-:- Thyroid Hormones
-:- Antithyroid Agents
-:- Thioamides
-:- Anion Inhibitors
-:- Iodides
-:- Radioactive Iodine
-:- Adrenoceptor-Blocking Agents
-:- Hypothyroidism
-:- Hyperthyroidism
-:- Nontoxic Goiter
-:- Thyroid Neoplasms
-:- Adrenocorticosteroids
-:- The Naturally Occurring Glucocorticoids; Cortisol (Hydrocortisone)
-:- Synthetic Corticosteroids
-:- Clinical Pharmacology - Synthetic Corticosteroids
-:- Toxicity - Synthetic Corticosteroids
-:- Contraindications & Cautions - Synthetic Corticosteroids
-:- Selection of Drug & Dosage Schedule - Synthetic Corticosteroids
-:- Mineralocorticoids (Aldosterone, Deoxycorticosterone, Fludrocortisone)
-:- Adrenal Androgens
-:- Synthesis Inhibitors & Glucocorticoid Antagonists
-:- Mineralocorticoid Antagonists
-:- Disturbances in Ovarian Function
-:- The Estrogens
-:- Physiologic Effects - The Estrogens
-:- Clinical Uses - The Estrogens
-:- Adverse Effects - The Estrogens
-:- Preparations & Dosages - The Estrogens
-:- The Progestins
-:- Other Ovarian Hormones
-:- Hormonal Contraception
-:- Pharmacologic Effects - Hormonal Contraception
-:- Clinical Uses - Hormonal Contraception
-:- Adverse Effects - Hormonal Contraception
-:- Contraindications & Cautions - Hormonal Contraception
-:- Contraception with Progestins Alone - Hormonal Contraception
-:- Tamoxifen & Related Partial Agonist Estrogens
-:- Mifepristone
-:- Danazol
-:- Other Inhibitors
-:- Ovulation-Inducing Agents
-:- The Testis
-:- Androgens & Anabolic Steroids
-:- Metabolism - The Testis
-:- Androgen Suppression & Antiandrogens
-:- Chemical Contraception in Men
-:- The Endocrine Pancreas
-:- Insulin
-:- Characteristics of Available Insulin Preparations
-:- Insulin Delivery Systems
-:- Treatment with Insulin, Benefit of Glycemic Control in Diabetes Mellitus
-:- Insulin Regimens
-:- Benefits of Tight Glycemic Control in Diabetes
-:- Insulin Treatment of Special Circumstances
-:- Complications of Insulin Therapy
-:- Oral Antidiabetic Agents
-:- Insulin Secretagogues: Sulfonylureas
-:- First-Generation Sulfonylureas
-:- Second-Generation Sulfonylureas
-:- Insulin Secretagogue: Meglitinide
-:- Insulin Secretagogue: D-Phenylalanine Derivative
-:- Biguanides
-:- Thiazolidinediones
-:- Alpha-Glucosidase Inhibitors
-:- Bile Acid Sequestrants
-:- Amylin Analog
-:- Glucagon-Like Polypeptide-1 (GLP-1) Receptor Agonists
-:- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
-:- Combination Therapy-Oral Antidiabetic Agents & Injectable Medication
-:- Glucagon
-:- Islet Amyloid Polypeptide IAPP, Amylin
-:- Basic Pharmacology
-:- Parathyroid Hormone - Principal Hormonal Regulators of Bone Mineral Homeostasis
-:- Vitamin D - Principal Hormonal Regulators of Bone Mineral Homeostasis
-:- Fibroblast Growth Factor 23 - Principal Hormonal Regulators of Bone Mineral Homeostasis
-:- Interaction of PTH, FGF23, & Vitamin D
-:- Secondary Hormonal Regulators of Bone Mineral Homeostasis
-:- Newer Therapies for Osteoporosis
-:- Nonhormonal Agents Affecting Bone Mineral Homeostasis
-:- Clinical Pharmacology - Agents That Affect Bone Mineral Homeostasis
-:- Abnormal Serum Calcium & Phosphate Levels
-:- Specific Disorders Involving Bone Mineral-Regulating Hormones
-:- Other Disorders of Bone Mineral Homeostasis
-:- Introduction to Antimicrobial Agents
-:- Beta Lactam Compounds: Penicillins
-:- Cephalosporins & Cephamycins
-:- Monobactams - Beta Lactam Drugs
-:- Beta-Lactamase Inhibitors (Clavulanic Acid, Sulbactam, & Tazobactam) - Beta Lactam Drugs
-:- Carbapenems - Beta Lactam Drugs
-:- Glycopeptide Antibiotics
-:- Other Cell Wall or Membrane Active Agents
-:- Tetracyclines
-:- Macrolides
-:- Erythromycin - Macrolides
-:- Clarithromycin - Macrolides
-:- Azithromycin - Macrolides
-:- Ketolides - Macrolides
-:- Clindamycin
-:- Streptogramins
-:- Chloramphenicol
-:- Oxazolidinones
-:- General Properties of Aminoglycosides
-:- Streptomycin
-:- Gentamicin
-:- Tobramycin
-:- Amikacin
-:- Netilmicin
-:- Neomycin & Kanamycin
-:- Spectinomycin
-:- Sulfonamides - Antifolate Drugs
-:- Trimethoprim & Trimethoprim-Sulfamethoxazole Mixtures - Antifolate Drugs
-:- Dna Gyrase Inhibitors : Fluoroquinolones
-:- Antimycobacterial Drugs
-:- Drugs Used In Tuberculosis
-:- Isoniazid - Drugs Used In Tuberculosis
-:- Rifampin - Drugs Used In Tuberculosis
-:- Ethambutol - Drugs Used In Tuberculosis
-:- Pyrazinamide - Drugs Used In Tuberculosis
-:- Streptomycin - Drugs Used In Tuberculosis
-:- Second-Line Drugs for Tuberculosis
-:- Rifaximin
-:- Drugs Active Against Atypical Mycobacteria
-:- Drugs Used in Leprosy
-:- Antifungal Agents
-:- Amphotericin B
-:- Flucytosine
-:- Azoles
-:- Echinocandins
-:- Oral Systemic Antifungal Drugs for Mucocutaneous Infections
-:- Topical Antifungal Therapy
-:- Antiviral Agents
-:- Agents to Treat Herpes Simplex Virus HSV & Varicella Zoster Virus VZV Infections
-:- Agents to Treat Cytomegalovirus CMV Infections
-:- Antiretroviral Agents
-:- Nucleoside & Nucleotide Reverse Transcriptase Inhibitors
-:- Nonnucleoside Reverse Transcriptase Inhibitors
-:- Protease Inhibitors
-:- Entry Inhibitors
-:- Integrase Strand Transfer Inhibitors
-:- New & Investigational Antiretroviral Agents
-:- Treatment of Hepatitis B Virus Infection
-:- Treatment of Hepatitis C Infection
-:- Anti Influenza Agents
-:- Other Antiviral Agents
-:- Metronidazole
-:- Mupirocin
-:- Polymyxins
-:- Fidaxomicin
-:- Urinary Antiseptics
-:- Disinfectants, Antiseptics, & Sterilants
-:- Alcohols - Disinfectants, Antiseptics, & Sterilants
-:- Chlorhexidine - Disinfectants, Antiseptics, & Sterilants
-:- Halogens - Disinfectants, Antiseptics, & Sterilants
-:- Phenolics - Disinfectants, Antiseptics, & Sterilants
-:- Quaternary Ammonium Compounds
-:- Aldehydes - Disinfectants, Antiseptics, & Sterilants
-:- Superoxidized Water - Disinfectants, Antiseptics, & Sterilants
-:- Peroxygen Compounds - Disinfectants, Antiseptics, & Sterilants
-:- Heavy Metals - Disinfectants, Antiseptics, & Sterilants
-:- Sterilants - Disinfectants, Antiseptics, & Sterilants
-:- Preservatives - Disinfectants, Antiseptics, & Sterilants
-:- Clinical Use of Antimicrobial Agents
-:- Empiric Antimicrobial Therapy
-:- Antimicrobial Therapy of Infections with Known Etiology
-:- Management of Antimicrobial Drug Toxicity
-:- Antimicrobial Drug Combinations
-:- Antimicrobial Prophylaxis
-:- Parasite Life Cycle - Malaria
-:- Drug Classification - Malaria
-:- Chemoprophylaxis & Treatment - Malaria
-:- Malaria: Chloroquine
-:- Other Quinolines - Malaria
-:- Artemisinin & Its Derivatives - Malaria
-:- Quinine & Quinidine - Malaria
-:- Mefloquine - Malaria
-:- Primaquine - Malaria
-:- Atovaquone - Malaria
-:- Inhibitors of Folate Synthesis - Malaria
-:- Antibiotics - Malaria
-:- Halofantrine & Lumefantrine - Malaria
-:- Treatment of Specific Forms of Amebiasis
-:- Metronidazole & Tinidazole
-:- Iodoquinol
-:- Diloxanide Furoate
-:- Paromomycin Sulfate
-:- Emetine & Dehydroemetine
-:- Pentamidine Antiprotozoal Drugs
-:- Sodium Stibogluconate Antiprotozoal Drugs
-:- Nitazoxanide Antiprotozoal Drugs
-:- Other Drugs for Trypanosomiasis & Leishmaniasis
-:- Chemotherapy of Helminthic Infections
-:- Albendazole
-:- Bithionol
-:- Diethylcarbamazine Citrate
-:- Doxycycline
-:- Ivermectin
-:- Mebendazole
-:- Metrifonate (Trichlorfon)
-:- Niclosamide
-:- Oxamniquine
-:- Piperazine
-:- Praziquantel
-:- Pyrantel Pamoate
-:- Thiabendazole
-:- Cancer Chemotherapy
-:- Causes of Cancer
-:- Cancer Treatment Modalities
-:- Role of Cell Cycle Kinetics & Anticancer Effect
-:- Drug Resistance - Cancer Chemotherapy
-:- Alkylating Agents - Pharmacology of Cancer Chemotherapeutic Drugs
-:- Nitrosoureas
-:- Nonclassic Alkylating Agents
-:- Platinum Analogs
-:- Antimetabolites
-:- Antifolates
-:- Fluoropyrimidines
-:- Deoxycytidine Analogs
-:- Purine Antagonists
-:- Vinca Alkaloids
-:- Taxanes & Related Drugs
-:- Epipodophyllotoxins
-:- Camptothecins
-:- Antitumor Antibiotics
-:- Miscellaneous Anticancer Drugs
-:- Clinical Pharmacology of Cancer Chemotherapeutic Drugs
-:- The Leukemias
-:- Hodgkin’s Lymphoma
-:- Non-Hodgkin’s Lymphoma
-:- Multiple Myeloma
-:- Breast Cancer
-:- Gastrointestinal Cancers
-:- Lung Cancer
-:- Ovarian Cancer
-:- Testicular Cancer
-:- Malignant Melanoma
-:- Brain Cancer
-:- Secondary Malignancies & Cancer Chemotherapy
-:- Immunopharmacology
-:- Normal Immune Responses
-:- Abnormal Immune Responses
-:- Glucocorticoids - Immunosuppressive Agents
-:- Calcineurin Inhibitors - Immunosuppressive Agents
-:- Mammalian Target Of Rapamycin (mTOR) Inhibitors
-:- Mycophenolate Mofetil - Immunosuppressive Agents
-:- Immunomodulatory Derivatives Of Thalidomide (IMiDs)
-:- Cytotoxic Agents - Immunosuppressive Agents
-:- Immunosuppressive Antibodies
-:- Monoclonal Antibodies (MABs)
-:- Clinical Uses of Immunosuppressive Drugs
-:- Immunologic Reactions to Drugs & Drug Allergy
-:- Immediate (Type I) Drug Allergy
-:- Autoimmune (Type Ii) Reactions to Drugs
-:- Serum Sickness & Vasculitic (Type III) Reactions
-:- Introduction to Toxicology: Occupational & Environmental
-:- Toxicologic Terms & Definitions
-:- Environmental Considerations - Toxicology
-:- Air Pollutants - Specific Chemicals
-:- Solvents - Specific Chemicals
-:- Pesticides - Specific Chemicals
-:- Herbicides - Specific Chemicals
-:- Environmental Pollutants - Specific Chemicals
-:- Metals - Specific Chemicals
-:- Toxicology of Lead
-:- Major Forms of Lead Intoxication
-:- Treatment - Toxicology of Lead
-:- Toxicology of Arsenic
-:- Pharmacokinetics, Pharmacodynamics - Toxicology of Arsenic
-:- Major Forms of Arsenic Intoxication
-:- Toxicology of Mercury
-:- Pharmacokinetics - Toxicology of Mercury
-:- Major Forms of Mercury Intoxication
-:- Treatment - Toxicology of Mercury
-:- Pharmacology of Chelators
-:- Dimercaprol (2,3-Dimercaptopropanol, BAL)
-:- Succimer (Dimercaptosuccinic ACID, DMSA)
-:- Edetate Calcium Disodium (Ethylenediaminetetraacetic Acid, EDTA)
-:- Unithiol (Dimercaptopropanesulfonic Acid, DMPS)
-:- Penicillamine (D-Dimethlcysteine)
-:- Deferoxamine
-:- Deferasirox
-:- Prussian Blue (Ferric Hexacyanoferrate)
-:- Management of the Poisoned Patient
-:- Toxicokinetics & Toxicodynamics
-:- Approach to the Poisoned Patient
-:- Initial Management of the Poisoned Patient
-:- Toxic Syndromes: Acetaminophen
-:- Toxic Syndromes: Amphetamines & Other Stimulants
-:- Toxic Syndromes: Anticholinergic Agents
-:- Toxic Syndromes: Antidepressants
-:- Toxic Syndromes: Antipsychotics
-:- Toxic Syndromes: Aspirin (Salicylate)
-:- Toxic Syndromes: Beta Blockers
-:- Toxic Syndromes: Calcium Channel Blockers
-:- Toxic Syndromes: Cholinesterase Inhibitors
-:- Toxic Syndromes: Cyanide
-:- Toxic Syndromes: Digoxin
-:- Toxic Syndromes: Ethanol & Sedative-Hypnotic Drugs
-:- Toxic Syndromes: Ethylene Glycol & Methanol
-:- Toxic Syndromes: Rattlesnake Envenomation
-:- Toxic Syndromes: Theophylline
-:- Drug Therapy in Pregnancy
-:- Drug Therapy in Infants & Children
-:- Pediatric Dosage Forms & Compliance
-:- Drug Use During Lactation
-:- Pediatric Drug Dosage
-:- Special Aspects of Geriatric Pharmacology
-:- Pharmacologic Changes Associated With Aging
-:- Central Nervous System Drugs
-:- Cardiovascular Drugs
-:- Antimicrobial Drugs
-:- Anti-Inflammatory Drugs
-:- Ophthalmic Drugs
-:- Adverse Drug Reactions in the Elderly
-:- Practical Aspects of Geriatric Pharmacology
-:- Dermatologic Pharmacology
-:- Dermatologic Vehicles
-:- Antibacterial Agents
-:- Antifungal Agents
-:- Oral Antifungal Agents
-:- Topical Antiviral Agents
-:- Immunomodulators
-:- Ectoparasiticides
-:- Agents Affecting Pigmentation
-:- Sunscreens
-:- Acne Preparations
-:- Drugs for Psoriasis
-:- Biologic Agents
-:- Anti Inflammatory Agents
-:- Keratolytic & Destructive Agents
-:- Antipruritic Agents
-:- Trichogenic & Antitrichogenic Agents
-:- Antineoplastic Agents
-:- Antiseborrhea Agents
-:- Drugs Used in the Treatment of Gastrointestinal Diseases
-:- Physiology of Acid Secretion - Agents that Reduce Intragastric Acidity
-:- Antacids - Agents that Reduce Intragastric Acidity
-:- H2-Receptor Antagonists - Agents that Reduce Intragastric Acidity
-:- Proton Pump Inhibitors
-:- Mucosal Protective Agents
-:- Drugs Stimulating Gastrointestinal Motility
-:- Laxatives
-:- Antidiarrheal Agents
-:- Drugs Used in the Treatment of Irritable Bowel Syndrome
-:- Antiemetic Agents
-:- Drugs Used to Treat Inflammatory Bowel Disease
-:- Aminosalicylates
-:- Glucocorticoids
-:- Purine Analogs: Azathioprine & 6-Mercaptopurine
-:- Methotrexate
-:- Anti-Tumor Necrosis Factor Therapy
-:- Anti-Integrin Therapy
-:- Pancreatic Enzyme Supplements
-:- Bile Acid Therapy For Gallstones
-:- Drugs Used to Treat Variceal Hemorrhage
-:- Dietary Supplements & Herbal Medications
-:- Historical & Regulatory Factors - Dietary Supplements & Herbal Medications
-:- Clinical Aspects of the Use of Botanicals
-:- Botanical Substances: Echinacea (Echinacea Purpurea)
-:- Botanical Substances: Garlic (Allium Sativum)
-:- Botanical Substances: Ginkgo (Ginkgo Biloba)
-:- Botanical Substances: Ginseng
-:- Botanical Substances: Milk Thistle (Silybum Marianum)
-:- St. John’s Wort (Hypericumperforatum)
-:- Saw Palmetto (Serenoa Repens Orsabal Serrulata)
-:- Coenzyme Q10
-:- Glucosamine
-:- Melatonin
-:- Rational Prescribing
-:- The Prescription
-:- Prescribing Errors
-:- E-Prescribing
-:- Compliance
-:- Who May Prescribe?
-:- Socioeconomic Factors
-:- The Cost of Prescriptions